CHICAGO (Reuters) - A quick eye scan might offer a cheap, painless way to track the progression of multiple sclerosis, U.S. researchers said on Monday. Sign up here. By scanning nerve fibers of the ...
Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. The Johnson & Johnson-partnered asset, ...
An estimated 2.8 million people worldwide have multiple sclerosis (MS). This autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback